This site is intended for Healthcare professionals only.

USFDA inspects Dahej facility, no observations issued: Ajanta Pharma


USFDA inspects Dahej facility, no observations issued: Ajanta Pharma

New Delhi: Drug firm Ajanta Pharma said the US health regulator has not made any observations after completion of inspection of its Dahej facility in Gujarat.

“Our formulation facility at Dahej was inspected by US FDA from July 23-27, 2018. At the end of the inspection, no Form 483 was issued to us,” Ajanta Pharma said in a BSE filing.

US Food and Drug Administration (USFDA) issues Form 483 to a company’s management after completion of inspection of its facility to notify regarding objectionable conditions.



Source: PTI
0 comment(s) on USFDA inspects Dahej facility, no observations issued: Ajanta Pharma

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted